Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arcadia Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arcadia Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Yoder Amy | Director | – | Sep 14, 2026 | 1 |
| Comcowich Kevin | Director | – | Sep 14, 2026 | 1 |
| Waller Gregory D | Director | – | Sep 14, 2026 | 1 |
| Murray Lilian Shackelford | Director | – | Sep 14, 2026 | 1 |
| Schaefer Thomas J. | Chief Executive Officer | 2,819 | May 12, 2025 | 0 |
| Kawakami Mark | Chief Financial Officer | 2,681 | May 12, 2025 | 0 |
| Bolles Albert D. | Director | – | Aug 21, 2024 | 0 |
| Carosella Deborah D | Director | – | Aug 21, 2024 | 0 |
| Jacot Stanley Jr | Chief Executive Officer | 5,000 | May 30, 2023 | 0 |
| Pitlik Laura | Chief Marketing Officer | – | Apr 28, 2023 | 0 |
| Haley Pamela | Chief Financial Officer | 5,088 | Aug 18, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.49 | +$1.74K | +35.3%2.68K after | |
| Feb 5, 2025 (view filing) | Feb 3 | 2 days | Schaefer Thomas J.Chief Executive Officer | PPurchase | +700 | $2.49 | +$1.74K | +33.0%2.82K after | |
| Aug 20, 2024 (view filing) | Aug 1 | 19 daysLate | Kawakami MarkChief Financial Officer | PPurchase | +700 | $2.06 | +$1.44K | +54.6%1.98K after | |
| Aug 20, 2024 (view filing) | Aug 1 | 19 daysLate | Schaefer Thomas J.Chief Executive Officer | PPurchase | +700 | $2.06 | +$1.44K | +49.3%2.12K after | |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Schaefer Thomas J.Chief Financial Officer | PPurchase | +700 | $2.06 | +$1.44K | +97.4%1.42K after | |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Schaefer Thomas J.Chief Financial Officer | PPurchase | +649 | $3.67 | +$2.38K | +927.1%719 after | |
| May 30, 2023 (view filing) | May 30 | Same day | Jacot Stanley JrChief Executive Officer | PPurchase | +5.00K | $4.31 | +$21.6K | New position5.00K after | |
| Feb 2, 2023 (view filing)7:07 PM ET | Feb 1 | 1 day | Schaefer Thomas J.Chief Financial Officer | PPurchase | +700 | $0.23 | +$161 | +33.3%2.80K after | |
| Aug 3, 2022 (view filing) | Aug 1 | 2 days | Haley PamelaChief Financial Officer | PPurchase | +700 | $0.70 | +$490 | +16.0%5.09K after |